Treatments of Osteoporosis: Choosing and Managing Them

·

Share

If you’ve just been told your T-score is -2.5 or lower, here’s the short answer: most people start on an oral bisphosphonate (alendronate or risedronate), take 1,000–1,200 mg of calcium and 800–1,000 IU of vitamin D daily, and get a repeat DEXA scan in about two years. If you’ve already broken a hip or spine, or your T-score is below -3.0, your doctor may skip straight to a stronger option like denosumab, zoledronic acid, or a bone-building drug such as teriparatide or romosozumab.

Choosing and managing treatments of osteoporosis isn’t a one-and-done decision. These drugs work differently, carry different risks, and — critically — some of them can’t simply be stopped without a plan. Below is how I walk patients through it in clinic.

Who Actually Needs Drug Treatment?

Not every low bone density result requires medication. Treatment is generally recommended when one of these applies:

  • A DEXA T-score of -2.5 or lower at the hip, femoral neck, or lumbar spine
  • A fragility fracture — a break from a fall from standing height or less, especially hip or vertebral
  • Osteopenia (T-score between -1.0 and -2.5) plus a high 10-year fracture risk on the FRAX calculator — typically ≥3% for hip fracture or ≥20% for major osteoporotic fracture

Osteoporosis is often called a silent disease because bone loss produces no symptoms at all. The first clue is frequently a wrist fracture from catching yourself on an outstretched hand, or losing more than 1.5 inches of height — a red flag for undiagnosed vertebral compression fractures.

Comparing the Treatments of Osteoporosis

Osteoporosis drugs fall into two camps. Antiresorptives slow the cells that break bone down. Anabolics actively build new bone. Anabolics are more powerful but are reserved for higher-risk patients and are limited in how long you can use them.

Drug Class How It’s Given Typical Duration Key Considerations
Alendronate / Risedronate Bisphosphonate Weekly oral tablet 5 years Must take on empty stomach, upright 30 min; esophageal irritation common
Zoledronic acid Bisphosphonate IV once yearly 3 years Flu-like reaction after first dose; avoid if eGFR <35
Denosumab RANKL inhibitor Injection every 6 months Indefinite Cannot be stopped abruptly — rebound vertebral fractures
Teriparatide / Abaloparatide PTH analogue (anabolic) Daily self-injection Up to 2 years Must be followed by an antiresorptive
Romosozumab Sclerostin inhibitor (anabolic) Monthly injection 12 months Avoid with recent heart attack or stroke
Raloxifene SERM Daily oral tablet Variable Reduces spine fractures only; raises clot risk
Estrogen therapy Hormone therapy Oral or transdermal Varies Best for women with menopausal symptoms under 60

Why Sequence Matters

Order of treatment changes the outcome. Giving an anabolic first, then following with a bisphosphonate, produces greater bone density gains than the reverse. If you go straight from a bisphosphonate to teriparatide, the early response is blunted.

That’s a conversation worth having up front if you’re at very high risk — not after you’ve already spent five years on alendronate.

Managing Therapy Long Term

The Bisphosphonate Drug Holiday

Bisphosphonates bind to bone and keep working after you stop. After 5 years of oral therapy (or 3 years of IV zoledronic acid), patients at moderate risk can often take a drug holiday of 2–3 years, with bone density rechecked periodically.

Patients at high risk — prior hip fracture, T-score still below -2.5, ongoing steroid use — generally continue to 10 years with oral therapy or 6 years with IV.

The Denosumab Rule You Can’t Break

Denosumab is different. It does not deposit in bone, and skipping doses triggers a surge in bone turnover that can cause multiple vertebral fractures within months. There is no such thing as a denosumab holiday.

If you stop, you must transition to a bisphosphonate. Set a calendar reminder for every injection — the 6-month window is not flexible.

Monitoring You Should Expect

  • Repeat DEXA every 1–2 years while on treatment, on the same machine when possible
  • Serum calcium and vitamin D before starting denosumab or IV bisphosphonates — hypocalcemia is a real risk if you’re deficient
  • Kidney function before each zoledronic acid infusion
  • Dental exam before starting, and complete any invasive dental work first

Side Effects Worth Knowing About

Two rare complications get a lot of attention: osteonecrosis of the jaw and atypical femoral fractures. Both are genuinely uncommon at osteoporosis doses — far rarer than the hip fractures these drugs prevent.

Still, tell your doctor immediately about new thigh or groin pain, which can precede an atypical fracture by weeks, or a non-healing sore in the mouth after dental work.

The far more common issues are practical: heartburn from oral bisphosphonates (usually fixable by switching to IV), and the transient fever and body aches after a first zoledronic acid infusion (pre-treat with acetaminophen).

Lifestyle Measures That Actually Move the Needle

Medication does the heavy lifting, but these matter:

  • Protein and calcium: aim for dietary calcium first — dairy, fortified plant milks, sardines, leafy greens. Supplement only the gap.
  • Vitamin D: target a serum 25-OH vitamin D above 30 ng/mL.
  • Resistance and weight-bearing exercise: two to three sessions weekly. Progressive resistance training beats walking alone.
  • Balance training: tai chi and similar programs reduce falls, which is what actually breaks bones.
  • Stop smoking, cap alcohol at two drinks daily or fewer.
  • Home safety: remove throw rugs, add grab bars, review medications that cause dizziness.

When to See a Doctor

Book an appointment if you:

  • Broke a bone after a minor fall at age 50 or older
  • Have lost height, developed a stooped posture, or have sudden mid-back pain
  • Are a woman past menopause with a parent who had a hip fracture
  • Have taken prednisone 5 mg daily or more for over three months
  • Are due for a denosumab injection and have missed the window

Frequently Asked Questions

How long does it take for osteoporosis treatment to work?

Fracture risk starts dropping within 6–12 months, before bone density changes much. Measurable DEXA improvement usually takes 18–24 months.

Can osteoporosis be reversed?

Bone density can improve meaningfully — anabolic agents can raise spine density substantially over 12–24 months — but the underlying fragility requires ongoing management. It’s controlled, not cured.

Do I still need calcium supplements if I’m on medication?

Osteoporosis drugs need adequate calcium and vitamin D to work. If your diet supplies 1,000–1,200 mg daily, you don’t need a pill. Most people fall short by 300–500 mg.

Does osteoporosis ever affect young people?

Yes. Children and adolescents can develop it from genetic conditions, chronic illness, or medications — see this overview of juvenile osteoporosis causes, diagnosis, and treatment.

Is it safe to have dental implants while on a bisphosphonate?

Generally yes at osteoporosis doses, but tell your dentist. Ideally schedule invasive dental work before starting therapy or during a drug holiday.

Key Takeaways

  • Treatment is warranted at a T-score of -2.5 or lower, after any fragility fracture, or with high FRAX risk
  • Bisphosphonates are first-line; anabolics come first for very high-risk patients
  • Bisphosphonates allow drug holidays — denosumab does not
  • Every anabolic course must be followed by an antiresorptive to lock in gains
  • Recheck DEXA every 1–2 years and address falls as aggressively as bone density

This article is for education and does not replace individual medical advice. Discuss treatment choices with your own clinician.

Written by
Blood Disorders, Bone Marrow Biology, Haematology
Contact [email protected] dskrausemdphd Website YaleMarch 23, 2020 Hematopoietic stem/progenitor cell fate specification in health and disease Diane Krause is a physician scientist and international leader in studies of adult stem cells and leukemia. Her research laboratory has made major discoveries regarding the transcriptional regulation of hematopoiesis with an emphasis on megakaryocyte fate specification and maturation as well as platelet function….
View Full Profile →
Web Admin Avatar